Semenya loses appeal against CAS ruling over testosterone
Double Olympic 800 metres champion Caster Semenya has lost her appeal to the Swiss Federal
Tribunal (SFT) to set aside a 2019 Court of Arbitration (CAS) ruling that female athletes with high natural
testosterone levels must take medication to reduce it.
The tribunal found the requirement of subjecting certain female athletes to drug or surgical interventions as a
precondition to compete does not amount to a violation of Swiss public policy, Semenya’s lawyers said in a
statement on Tuesday.
“I am very disappointed by this ruling, but refuse to let World Athletics drug me or stop me from being who I
am,” Semenya said in the statement.
“Excluding female athletes or endangering our health solely because of our natural abilities puts World Athletics
on the wrong side of history.
Semenya has already indicated that she would focus on the shorter 200 metres sprint event, which falls outside
of the regulations, at the Tokyo Olympic Games that were postponed to next year due to the COVID-19
“This setback will not be the end of Caster’s story,” he said. “The international team (of lawyers) is considering
the judgment and the options to challenge the findings in European and domestic courts.”